These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8172959

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Immunoscintigraphy results in the comparison of ocular with cutaneous melanoma].
    Löffler KU, Bräutigam P, Simon J, Althauser SR, Moser E, Witschel H.
    Ophthalmologe; 1994 Aug; 91(4):529-32. PubMed ID: 7950129
    [Abstract] [Full Text] [Related]

  • 3. Ocular radioimmunoscintigraphy: sensitivity and practical considerations.
    Bomanji J, Nimmon CC, Hungerford JL, Solanki K, Granowska M, Britton KE.
    J Nucl Med; 1988 Jun; 29(6):1031-7. PubMed ID: 3373313
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunoscintigraphy for ocular melanoma: a reliable diagnostic technique?
    Loeffler KU, Bräutigam P, Simon JC, Althauser SR, Wuttig C, Witschel H.
    Graefes Arch Clin Exp Ophthalmol; 1996 Feb; 234(2):100-4. PubMed ID: 8720679
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunoscintigraphy in malignant melanoma: a five-year clinical experience.
    Feggi L, Indelli M, Pansini GC, Santini A, Prandini N, Virgili AR.
    Nucl Med Commun; 1993 Feb; 14(2):145-8. PubMed ID: 8429994
    [Abstract] [Full Text] [Related]

  • 13. Noncutaneous melanoma have distinct features from each other and cutaneous melanoma.
    Tas F, Keskin S, Karadeniz A, Dağoğlu N, Sen F, Kilic L, Yildiz I.
    Oncology; 2011 Feb; 81(5-6):353-8. PubMed ID: 22248874
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Radioimmunoscintigraphy with a 99mTc-labeled F(ab')2 fragment of a monoclonal antibody (HMW-MAA 225.28S) in 71 patients with malignant melanoma].
    Rentsch M, Cerny T, Geiger L, Gerber H, Brunner KW, Rösler H, Nachbur B.
    Schweiz Med Wochenschr; 1989 Oct 07; 119(40):1382-5. PubMed ID: 2552577
    [Abstract] [Full Text] [Related]

  • 16. [Antigen pattern in choroid melanoma in correlation with immunoscintigraphy].
    Löffler KU, Simon JC, Wuttig C, Althauser SR, Bräutigam P, Witschel H.
    Ophthalmologe; 1995 Oct 07; 92(5):723-7. PubMed ID: 8751005
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic value of ocular melanoma immunoscintigraphy.
    Janković Z, Pucar D, Jauković L, Ajdinović B.
    J BUON; 2006 Oct 07; 11(3):347-50. PubMed ID: 17309161
    [Abstract] [Full Text] [Related]

  • 18. [Immunoscintigraphy with a technetium 99m-labeled monoclonal antibody in patients with melanoma].
    Dudczak R, Kletter K, Bailer H, Kokoschka E, Pohl-Markl H.
    Wien Klin Wochenschr; 1987 Apr 03; 99(7):232-9. PubMed ID: 3590802
    [Abstract] [Full Text] [Related]

  • 19. Scintigraphic visualization of ocular melanoma with Tc-99m glutathione.
    Tutuş A, Erkiliç K, Ercan MT, Kontaş O, Aydin M, Doğan H.
    Ann Nucl Med; 1997 May 03; 11(2):143-6. PubMed ID: 9212895
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.